AAAAAA

   
Results: 1-12 |
Results: 12
MOLECULAR-IDENTIFICATION OF INFECTIOUS AGENTS IN PRIMARY BILIARY-CIRRHOSIS
Authors: TANAKA A PRINDIVILLE T SOLNICK J COPPEL RL LAKE J KEEFFE E GISH R GERSHWIN ME
Citation: A. Tanaka et al., MOLECULAR-IDENTIFICATION OF INFECTIOUS AGENTS IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(4), 1998, pp. 301-301
EARLY CLEARANCE OF SERUM HCV RNA DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS-C DEMONSTRATES DIFFERENT PATTERNS OF RESPONSE AMONG HCV GENOTYPES
Authors: MCHUTCHISON J KEEFFE E TONG M BLATT L ALBERT D KLEIN M
Citation: J. Mchutchison et al., EARLY CLEARANCE OF SERUM HCV RNA DURING INTERFERON TREATMENT OF CHRONIC HEPATITIS-C DEMONSTRATES DIFFERENT PATTERNS OF RESPONSE AMONG HCV GENOTYPES, Hepatology, 28(4), 1998, pp. 485-485
IDENTIFICATION AND PRECURSOR FREQUENCY-ANALYSIS OF A COMMON T-CELL EPITOPE MOTIF IN PRIMARY BILIARY-CIRRHOSIS
Authors: SHIMODA S VANDEWATER J ANSARI A NAKAMURA M ISHIBASHI H COPPEL RL LAKE J KEEFFE E ROCHE TE GERSHWIN ME
Citation: S. Shimoda et al., IDENTIFICATION AND PRECURSOR FREQUENCY-ANALYSIS OF A COMMON T-CELL EPITOPE MOTIF IN PRIMARY BILIARY-CIRRHOSIS, Hepatology, 28(4), 1998, pp. 959-959
QUANTITATIVE AND QUALITATIVE DIFFERENCES TO RETREATMENT WITH CONSENSUS INTERFERON BY GENOTYPE
Authors: FROMM H KEEFFE E HEATHCOTE EJ LEE SS ALBERT D
Citation: H. Fromm et al., QUANTITATIVE AND QUALITATIVE DIFFERENCES TO RETREATMENT WITH CONSENSUS INTERFERON BY GENOTYPE, Hepatology, 28(4), 1998, pp. 2144-2144
PREDICTIVE VALUE OF THE TIMING OF ALT AND HCV RNA RESPONSES IN DEFINING PATIENTS WHO WILL HAVE A VIROLOGICAL-SUSTAINED RESPONSE AFTER 6 MONTHS OF INTERFERON THERAPY
Authors: KEEFFE E SMITH C LYCHE K
Citation: E. Keeffe et al., PREDICTIVE VALUE OF THE TIMING OF ALT AND HCV RNA RESPONSES IN DEFINING PATIENTS WHO WILL HAVE A VIROLOGICAL-SUSTAINED RESPONSE AFTER 6 MONTHS OF INTERFERON THERAPY, Gastroenterology, 114(4), 1998, pp. 301-301
DUAL EFFECTS OF HEPATITIS-B (HBV) INFECTION AND HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN REDUCING THE INCIDENCE OF ACUTE REJECTION POSTTRANSPLANTATION
Authors: PESSOA MG KIM E MARTIN P CRIPPIN J KEEFFE E GISH R ASCHER N WRIGHT TL TERRAULT NA
Citation: Mg. Pessoa et al., DUAL EFFECTS OF HEPATITIS-B (HBV) INFECTION AND HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN REDUCING THE INCIDENCE OF ACUTE REJECTION POSTTRANSPLANTATION, Gastroenterology, 114(4), 1998, pp. 507-507
IMPROVED SURVIVAL OF HEPATITIS-B PATIENTS UNDERGOING LIVER-TRANSPLANTATION - EFFECTS INDEPENDENT OF THERAPEUTIC INTERVENTIONS
Authors: TERRAULT NA PESSOA MG SINGLETON S KIM E MARTIN P CRIPPIN J GISH R KEEFFE E LAKE J ASCHER N WRIGHT TL
Citation: Na. Terrault et al., IMPROVED SURVIVAL OF HEPATITIS-B PATIENTS UNDERGOING LIVER-TRANSPLANTATION - EFFECTS INDEPENDENT OF THERAPEUTIC INTERVENTIONS, Hepatology, 26(4), 1997, pp. 195-195
RELATIONSHIP BETWEEN BIOCHEMICAL AND VIROLOGICAL RESPONSE TO TYPE-1 INTERFERON THERAPY OF CHRONIC HCV INFECTION
Authors: POCKROS PJ TONG MJ LEE WM VANLEEUWEN DJ KEEFFE E BALA K KILLENBERG PG FOUST RT ROSENBLATE HJ PAYNE KM FROMM H LESESNE HR BLACK M SNYDER R GERRARD T CONRAD A BLATT LM
Citation: Pj. Pockros et al., RELATIONSHIP BETWEEN BIOCHEMICAL AND VIROLOGICAL RESPONSE TO TYPE-1 INTERFERON THERAPY OF CHRONIC HCV INFECTION, Hepatology, 24(4), 1996, pp. 113-113
TREATMENT OF HIGH VIRAL AFTER CHRONIC HCV PATIENTS WITH CONSENSUS INTERFERON (CIFN) RESULTS IN A SIGNIFICANTLY GREATER NUMBER OF SUSTAINED HCV RNA RESPONDERS AS COMPARED TO TREATMENT WITH INTERFERON-ALPHA-2B
Authors: JENSEN DM BLATT LM TONG MJ LEE WM MULLEN K HOEFS JC KEEFFE E HOLLINGER FB HEATHCOTE EJL WHITE H FOUST RT KRAWITT EL FROMM H BLACK M ALBERT D GERRARD T
Citation: Dm. Jensen et al., TREATMENT OF HIGH VIRAL AFTER CHRONIC HCV PATIENTS WITH CONSENSUS INTERFERON (CIFN) RESULTS IN A SIGNIFICANTLY GREATER NUMBER OF SUSTAINED HCV RNA RESPONDERS AS COMPARED TO TREATMENT WITH INTERFERON-ALPHA-2B, Hepatology, 24(4), 1996, pp. 593-593
DIFFERENTIAL RESPONSE TO TREATMENT WITH CONSENSUS INTERFERON (CIFN) AND IFN ALPHA-2B IN CHRONIC HCV PATIENTS INFECTED WITH DIFFERENT
Authors: KEEFFE E BLATT LM DUSHEIKO G TONG MJ HOLLINGER FB JAMES S MULLEN K EVERSON G PIMSTONE N HEATHCOTE EJL DONOVAN J CONRAD A SCHMID P ALBERT D GERRARD T
Citation: E. Keeffe et al., DIFFERENTIAL RESPONSE TO TREATMENT WITH CONSENSUS INTERFERON (CIFN) AND IFN ALPHA-2B IN CHRONIC HCV PATIENTS INFECTED WITH DIFFERENT, Hepatology, 24(4), 1996, pp. 594-594
BIOCHEMICAL AND VIROLOGICAL RESPONSE TO CONSENSUS INTERFERON (CIFN) IN LOW VIRAL TITER CHRONIC HCV PATIENTS
Authors: KRAWITT EL BLATT LM TONG MJ LEE WM MULLEN K HOEFS JC KEEFFE E HOLLINGER FB HEATHCOTE EJL WHILE H FOUST RT JENSEN DM FROMM H BLACK M ALBERT D GERRARD T
Citation: El. Krawitt et al., BIOCHEMICAL AND VIROLOGICAL RESPONSE TO CONSENSUS INTERFERON (CIFN) IN LOW VIRAL TITER CHRONIC HCV PATIENTS, Hepatology, 24(4), 1996, pp. 1632-1632
SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS
Authors: MINER P HANAUER S ROBINSON M SCHWARTZ J ARORA S BRIGGS RL LAWLIS V FELGER C KITZMILLER G LIEBERMANN T FRACHTMAN R FISCHER C CELLO JP GRENDELL J SATOW J HANAUER SB HANAN I SCHULTZ P JAMES D MERTESDORF J HIESTAND F TUCKER P ROBERTS T BRUNDAGE P GRIFFIN T BECK JE RICK G HARTONG W BUSER W BRAND S BRYANT P KLIEWER M MELLOW M MCFADDEN R NEUMANN D HELIN K PRIVETTCOINTEPAS CJ MEEK RR ROUFAIL W BRICE R HUGHES TP FINA M MURPHY D CLINARD L ALLMAN D BOWEN B SCHWARTZ JL JURCIK I WHITE LB COHEN M SALES D GOCHNOUR S YORK NM WEINBERG D DUBOW RA PRIES J TOMBERS J GILBERSTADT S HANNA P WATSON MJ MATTISON M SAFDI M SAFDI A SCHNEIDER R WAISSBLUTH G KRAINES MD MAGAW L EMRATH N KAPLAN M MCKUSICK A ROSENBERG F KIRCH EP ALLEN HA WEBER B BARRIERO MA BANK L GITCHELL L STRUM WB GOODMAN L MATTER S MILLER D ANTONSON C CHRISTIAN R BIDDLE W CLARK S SUTTON DS KATON RM SMITH F BENNER K KEEFFE E LIEBERMAN D MELNYK C LINDENBURG F WEBSTER S ZFASS A KIRBY D LEE A YEE YS GOSHGARIANPATRICK P BARISH C ASHBURN P WATERMAN DC PATTERSON PM CARLISLE WR OUTIM L TOBIAS R COCHRAN JL BRISTOW WJ MILLER PD INGLE S KERR RM CASTELL D WU WC RICHTER JE GILLIAM JH STARK G LAW R MALONE N ROI L COEN M MOORE D MCPHERSON M
Citation: P. Miner et al., SAFETY AND EFFICACY OF CONTROLLED-RELEASE MESALAMINE FOR MAINTENANCE OF REMISSION IN ULCERATIVE-COLITIS, Digestive diseases and sciences, 40(2), 1995, pp. 296-304
Risultati: 1-12 |